Patients News | pharmaphorum

News

The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.

News

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad.

News

The shake-up of NHS England looks like it could go up a notch, as reports suggest thousands of job cuts that could halve its headcount are planned.

News

An observational study backed by Biogen has suggested that Apple smartphones and watches may be able to spot the signs of mild cognitive impairment.

News

President Trump's pick to lead the FDA, Martin Makary, was challenged on vaccines, the abortion pill, and FDA staffing decisions at a Senate hearing.

News

Eisai and Biogen have another chance to convince NICE that the NHS should cover the cost of Alzheimer's therapy Leqembi.